Efficacy of Two-phase Treatment Regimen for Rhino-facial Entomophthoromycosis: Our Experience and Review of Literature.

Azoles Basidiobolomycosis Entomophthoromycosis India Potassium Iodide Skin Zygomycosis

Journal

Oman medical journal
ISSN: 1999-768X
Titre abrégé: Oman Med J
Pays: Oman
ID NLM: 101526350

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 19 11 2020
accepted: 19 05 2021
entrez: 2 12 2022
pubmed: 3 12 2022
medline: 3 12 2022
Statut: epublish

Résumé

This paper reviews our institutional experience in the management of rhino-facial entomophthoromycosis, a rare subcutaneous fungal infection. We adopt a fixed two-phase protocol comprising an initial 'intensive phase' (two-drug regimen) followed by an 'eradication phase' (monotherapy). We present five patients treated between May 2013 and May 2020 in our institution who were subjected to the mentioned protocol. All five patients received six months of supersaturated potassium iodide solution and itraconazole, followed by four months of monotherapy with only supersaturated potassium iodide solution. All patients responded well to the treatment and were disease-free on follow-up of a minimum two years post-treatment. We recommend this procedure for all typical cases of entomophthoromycosis and suggest avoiding surgical intervention which may disseminate the fungus and delay response to treatment.

Identifiants

pubmed: 36458237
doi: 10.5001/omj.2022.29
pii: OMJ-37-06-2000230
pmc: PMC9664314
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e448

Informations de copyright

The OMJ is Published Bimonthly and Copyrighted 2022 by the OMSB.

Références

J Postgrad Med. 2015 Apr-Jun;61(2):143-4
pubmed: 25766357
Clin Microbiol Infect. 2004 Mar;10 Suppl 1:31-47
pubmed: 14748801
Ann Med Health Sci Res. 2013 Jul;3(3):397-401
pubmed: 24116321
Sultan Qaboos Univ Med J. 2018 Nov;18(4):e549-e552
pubmed: 30988980
J Clin Diagn Res. 2016 Dec;10(12):MJ01
pubmed: 28208896
Indian Dermatol Online J. 2015 Nov-Dec;6(6):393-5
pubmed: 26753137
Ear Nose Throat J. 2021 Sep;100(5_suppl):835S-841S
pubmed: 32204618
J Oral Maxillofac Pathol. 2020 Feb;24(Suppl 1):S124-S127
pubmed: 32189920
J Am Acad Dermatol. 2000 Oct;43(4):691-7
pubmed: 11004629
Lancet Infect Dis. 2021 Feb;21(2):296
pubmed: 33515527
Int J Dermatol. 2016 Feb;55(2):208-14
pubmed: 26234812
Indian J Otolaryngol Head Neck Surg. 2019 Nov;71(Suppl 3):1821-1826
pubmed: 31763253
Ann Med Surg (Lond). 2020 Jul 15;57:41-45
pubmed: 32714524
J Chin Med Assoc. 2014 Jun;77(6):337-40
pubmed: 24746408
J Family Med Prim Care. 2018 Sep-Oct;7(5):1113-1115
pubmed: 30598971
N Engl J Med. 2018 Mar 1;378(9):e13
pubmed: 29490172
J Pediatr Surg. 2015 Jul;50(7):1150-5
pubmed: 25783300

Auteurs

Srinivas Chadaram (S)

Ear, Nose, and Throat Department, All India Institute of Medical Sciences, Bhubaneswar, India.

Preetam Chappity (P)

Ear, Nose, and Throat Department, All India Institute of Medical Sciences, Bhubaneswar, India.

Vinaykumar Hallur (V)

Microbiology Department, All India Institute of Medical Sciences, Bhubaneswar, India.

Prity Sharma (P)

Ear, Nose, and Throat Department, All India Institute of Medical Sciences, Bhubaneswar, India.

Pradhan Pradeep (P)

Ear, Nose, and Throat Department, All India Institute of Medical Sciences, Bhubaneswar, India.

Pradipta Parida (P)

Ear, Nose, and Throat Department, All India Institute of Medical Sciences, Bhubaneswar, India.

Classifications MeSH